Samlyn Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-319,432
| Closed | -$36.4M | – | 123 |
|
|
2022
Q4 | $36.4M | Sell |
319,432
-1,242,001
| -80% | -$141M | 0.71% | 49 |
|
|
2022
Q3 | $96.6M | Sell |
1,561,433
-1,158,049
| -43% | -$71.7M | 1.8% | 18 |
|
|
2022
Q2 | $217M | Buy |
2,719,482
+265,447
| +11% | +$21.2M | 4.33% | 5 |
|
|
2022
Q1 | $258M | Buy |
2,454,035
+789,021
| +47% | +$83M | 3.71% | 4 |
|
|
2021
Q4 | $179M | Buy |
1,665,014
+521,934
| +46% | +$56.2M | 2.48% | 9 |
|
|
2021
Q3 | $125M | Sell |
1,143,080
-77,042
| -6% | -$8.44M | 1.68% | 17 |
|
|
2021
Q2 | $114M | Buy |
1,220,122
+191,922
| +19% | +$18M | 1.68% | 19 |
|
|
2021
Q1 | $94.6M | Sell |
1,028,200
-216,112
| -17% | -$19.9M | 1.31% | 28 |
|
|
2020
Q4 | $91M | Buy |
1,244,312
+525,296
| +73% | +$38.4M | 1.3% | 22 |
|
|
2020
Q3 | $55.9M | Sell |
719,016
-836,600
| -54% | -$65M | 1.01% | 29 |
|
|
2020
Q2 | $86.5M | Sell |
1,555,616
-108,688
| -7% | -$6.04M | 1.6% | 19 |
|
|
2020
Q1 | $49.3M | Buy |
1,664,304
+486,771
| +41% | +$14.4M | 1.24% | 32 |
|
|
2019
Q4 | $42.6M | Buy |
1,177,533
+142,700
| +14% | +$5.17M | 0.89% | 40 |
|
|
2019
Q3 | $28.2M | Buy |
1,034,833
+271,383
| +36% | +$7.39M | 0.68% | 44 |
|
|
2019
Q2 | $18.4M | Buy |
763,450
+475,457
| +165% | +$11.4M | 0.39% | 61 |
|
|
2019
Q1 | $7.61M | Buy |
+287,993
| New | +$7.61M | 0.18% | 76 |
|
|
2016
Q4 | – | Sell |
-728,700
| Closed | -$13.2M | – | 153 |
|
|
2016
Q3 | $13.2M | Buy |
+728,700
| New | +$13.2M | 0.31% | 85 |
|